Sutro Biopharma Stock Discussion

$Sutro Biopharma (STRO.US)$
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
Monday, 28th April at 4:05 pm
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced poster presentations at the upcoming 2025 American Association for Cancer Research (...

$Sutro Biopharma (STRO.US)$ still cheap boys and girls, still cheap

$Sutro Biopharma (STRO.US)$ load them up

$Sutro Biopharma (STRO.US)$ nice

$Sutro Biopharma (STRO.US)$ 👀👀👀👀

$Sutro Biopharma (STRO.US)$ good to buy now?

$Sutro Biopharma (STRO.US)$
Sutro's Cancer Drug Doubles Response Rate in Latest Trial, But Faces Uncertain Future

$Sutro Biopharma (STRO.US)$
Sutro Biopharma Unveils Major Strategic Shift with $317M War Chest Through 2026

$Sutro Biopharma (STRO.US)$
Boehringer Ingelheim And Sutro Biopharma Announced Successful Large-Scale Production Of Luvelta Using Sutro's Cell-Free Expression Technology For Ovarian Cancer Treatment; Achieved Industry Milestone With 4,500L GMP Batches Meeting Clinical Study...